JP2020518620A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020518620A5 JP2020518620A5 JP2019560246A JP2019560246A JP2020518620A5 JP 2020518620 A5 JP2020518620 A5 JP 2020518620A5 JP 2019560246 A JP2019560246 A JP 2019560246A JP 2019560246 A JP2019560246 A JP 2019560246A JP 2020518620 A5 JP2020518620 A5 JP 2020518620A5
- Authority
- JP
- Japan
- Prior art keywords
- particles
- pharmaceutical composition
- bioactive compound
- loaded
- mmad
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1750544-7 | 2017-05-04 | ||
| SE1750544 | 2017-05-04 | ||
| PCT/EP2018/061436 WO2018202818A1 (en) | 2017-05-04 | 2018-05-03 | A process for manufacturing porous silica particles loaded with at least one bioactive compound adapted for lung, nasal, sublingual and/or pharyngeal delivery |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020518620A JP2020518620A (ja) | 2020-06-25 |
| JP2020518620A5 true JP2020518620A5 (cg-RX-API-DMAC7.html) | 2021-03-25 |
| JP7048642B2 JP7048642B2 (ja) | 2022-04-05 |
Family
ID=62143135
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019560246A Expired - Fee Related JP7048642B2 (ja) | 2017-05-04 | 2018-05-03 | 肺、鼻、舌下および／または咽頭への送達に適した、少なくとも１つの生物活性化合物をロードした多孔質シリカ粒子の製造方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11285107B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3618811B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7048642B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102579524B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN110603034A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2018262708B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3059099C (cg-RX-API-DMAC7.html) |
| DK (1) | DK3618811T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2837675T3 (cg-RX-API-DMAC7.html) |
| PL (1) | PL3618811T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018202818A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3618811T3 (da) | 2017-05-04 | 2020-12-21 | Nanologica Ab | Fremgangsmåde til fremstilling af porøse siliciumdioxidpartikler ladet med mindst én biologisk aktiv forbindelse, der er tilpasset til pulmonal, nasal, sublingual og/eller pharyngeal tilførsel |
| GB201818164D0 (en) | 2018-11-07 | 2018-12-19 | Vicore Pharma Ab | New composition |
| IL286273B2 (en) * | 2019-03-24 | 2025-11-01 | Buzzelet Development And Technologies Ltd | Cannabis inhalation products and methods of production thereof |
| JP7394493B2 (ja) * | 2019-07-31 | 2023-12-13 | レモネックス インコーポレイテッド | 抗癌剤および多孔性シリカ粒子の製造方法 |
| GB201916121D0 (en) | 2019-11-06 | 2019-12-18 | Vicore Pharma Ab | New compositions |
| GB201916117D0 (en) | 2019-11-06 | 2019-12-18 | Vicore Pharma Ab | New compositions |
| GB201916130D0 (en) | 2019-11-06 | 2019-12-18 | Vicore Pharma Ab | New compositions |
| GB201916122D0 (en) | 2019-11-06 | 2019-12-18 | Nanologica Ab | New compositions |
| WO2021211738A1 (en) * | 2020-04-15 | 2021-10-21 | Sanford Burnham Prebys Medical Discovery Institute | Methods and compositions for antiviral treatment |
| US11793808B2 (en) | 2021-02-22 | 2023-10-24 | Mannkind Corp. | Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6254854B1 (en) | 1996-05-24 | 2001-07-03 | The Penn Research Foundation | Porous particles for deep lung delivery |
| GB2355711B (en) | 1999-10-27 | 2003-12-24 | Agilent Technologies Inc | Porous silica microsphere scavengers |
| US6485707B2 (en) | 2001-02-15 | 2002-11-26 | Aeropharm Technology Incorporated | Modulated release particles for aerosol delivery |
| US6544497B2 (en) | 2001-02-15 | 2003-04-08 | Aeropharm Technology Incorporated | Modulated release particles for aerosol delivery |
| US6596262B2 (en) | 2001-02-15 | 2003-07-22 | Aeropharm Technology Incorporated | Modulated release particles for aerosol delivery |
| GB0118689D0 (en) | 2001-08-01 | 2001-09-19 | Psimedica Ltd | Pharmaceutical formulation |
| US20040242729A1 (en) | 2003-05-30 | 2004-12-02 | 3M Innovative Properties Company | Stabilized particle dispersions containing surface-modified inorganic nanoparticles |
| FI20060428L (fi) | 2006-05-03 | 2007-11-04 | Esko Kauppinen | Pintamodifioidut aerosolihiukkaset, menetelmä ja laite niiden tuottamiseksi sekä jauheet ja dispersiot jotka sisältävät kyseisiä hiukkasia |
| US20100116743A1 (en) | 2007-06-04 | 2010-05-13 | James Neil Pryor | Silica particles and methods of making and using the same |
| GB0714134D0 (en) | 2007-07-19 | 2007-08-29 | Norton Healthcare Ltd | Dry-powder medicament |
| CA2698683A1 (en) | 2007-09-07 | 2009-03-12 | Epigenesis Pharmaceuticals, Llc | Dheas inhalation compositions |
| WO2009101110A2 (en) | 2008-02-11 | 2009-08-20 | Alfonso Garcia-Bennet | Method for manufacturing mesoporous materials, materials so produced and use of mesoporous materials. |
| JP5437232B2 (ja) | 2008-03-11 | 2014-03-12 | あすか製薬株式会社 | 固体分散体とその医薬組成物、並びにそれらの製造方法 |
| JP6073788B2 (ja) | 2010-09-14 | 2017-02-01 | ナノロジカ アクティエボラーグ | 難水溶性医薬及び化粧品有効成分のための過飽和送達媒体 |
| GB201212866D0 (en) * | 2012-07-20 | 2012-09-05 | Formac Pharmaceuticals Nv | Dry granulates of mesoporous silica powders |
| PL3104853T3 (pl) | 2014-02-10 | 2020-05-18 | Respivant Sciences Gmbh | Leczenie stabilizatorami komórek tucznych zaburzeń ogólnoustrojowych |
| WO2016013751A1 (ko) * | 2014-07-22 | 2016-01-28 | 주식회사 레모넥스 | 생리활성 물질 또는 단백질 전달용 조성물 및 이의 용도 |
| US20160090603A1 (en) * | 2014-09-30 | 2016-03-31 | Sandia Corporation | Delivery platforms for the domestication of algae and plants |
| WO2017023407A2 (en) * | 2015-06-01 | 2017-02-09 | Stc. Unm | Nanobiocomposite compositions and methods |
| ES2965015T3 (es) * | 2016-02-29 | 2024-04-10 | Emplicure Ab | Dispositivos de evaporación e inhalación de principios activos |
| DK3618811T3 (da) | 2017-05-04 | 2020-12-21 | Nanologica Ab | Fremgangsmåde til fremstilling af porøse siliciumdioxidpartikler ladet med mindst én biologisk aktiv forbindelse, der er tilpasset til pulmonal, nasal, sublingual og/eller pharyngeal tilførsel |
-
2018
- 2018-05-03 DK DK18723453.9T patent/DK3618811T3/da active
- 2018-05-03 CA CA3059099A patent/CA3059099C/en active Active
- 2018-05-03 EP EP18723453.9A patent/EP3618811B1/en active Active
- 2018-05-03 JP JP2019560246A patent/JP7048642B2/ja not_active Expired - Fee Related
- 2018-05-03 KR KR1020197035080A patent/KR102579524B1/ko active Active
- 2018-05-03 CN CN201880029084.8A patent/CN110603034A/zh active Pending
- 2018-05-03 US US16/609,854 patent/US11285107B2/en not_active Expired - Fee Related
- 2018-05-03 AU AU2018262708A patent/AU2018262708B2/en not_active Ceased
- 2018-05-03 PL PL18723453T patent/PL3618811T3/pl unknown
- 2018-05-03 ES ES18723453T patent/ES2837675T3/es active Active
- 2018-05-03 WO PCT/EP2018/061436 patent/WO2018202818A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102579524B1 (ko) | 폐, 비강, 설하 및/또는 인두 전달을 위해 조정된 하나 이상의 생활성 화합물로 로딩된 다공성 실리카 입자의 제조 방법 | |
| Meenach et al. | Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer | |
| Son et al. | Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: Effect of spray drying process conditions on aerosol performance | |
| JP2017505789A5 (cg-RX-API-DMAC7.html) | ||
| ITMI20012174A1 (it) | Polvere per somministrazione nasale di farmaci | |
| JP2016518388A (ja) | 乾燥粉末配合および使用方法 | |
| JP2019532068A (ja) | 噴霧乾燥組成物の製造方法及び噴霧乾燥装置 | |
| JP2008518007A (ja) | 肺感染症の処置のための粒子 | |
| CN108463213B (zh) | 可吸入扎鲁司特颗粒的制备 | |
| AU2015237857B2 (en) | Spray-dried solid-in-oil-in-water dispersions for inhalation of active pharmaceutical ingredients | |
| CN112469395A (zh) | 间质性肺病的新治疗 | |
| Li et al. | Innovative pMDI formulations of spray-dried nanoparticles for efficient pulmonary drug delivery | |
| Hamedani et al. | A novel particle engineering method for the production of inhalable cromolyn sodium powders by a combination of spray drier and nebulizer | |
| CN105434360A (zh) | 一种用于肺部给药的中空载药微球及其制备方法 | |
| Pawara et al. | Spray dried nanoparticle for pulmonary delivery: current developments and future perspectives | |
| Peštálová et al. | Modern trends in the formulation of microparticles for lung delivery using porogens: methods, principles and examples | |
| Ebrahimi et al. | Supercritical Fluid Technology as a Tool for Improved Drug Delivery to the Lungs | |
| Kumar et al. | Spray Dried Particles for Inhalation | |
| WO2021090013A1 (en) | New composition comprising amorphous nanoporous silica particles | |
| CN1638728A (zh) | 含有cgrp拮抗剂[bibn4096]的粉末吸入剂及其制备 | |
| JP2007502792A6 (ja) | Ｃｇｒｐアンタゴニスト１−［ｎ２−［３，５−ジブロモ−ｎ−［［４−（３，４−ジヒドロ−２（１ｈ）−オキソキナゾリン−３−イル）−１−ピペリジニル］カルボニル］−ｄ−チロシル］−ｌ−リシル］−４−（４−ピリジニル）−ピペラジンを含有する粉末製剤、その吸入粉末としての製造方法及び使用 | |
| JP2007502792A (ja) | Ｃｇｒｐアンタゴニスト１−［ｎ２−［３，５−ジブロモ−ｎ−［［４−（３，４−ジヒドロ−２（１ｈ）−オキソキナゾリン−３−イル）−１−ピペリジニル］カルボニル］−ｄ−チロシル］−ｌ−リシル］−４−（４−ピリジニル）−ピペラジンを含有する粉末製剤、その吸入粉末としての製造方法及び使用 | |
| Ruiz | Advanced spray dried proliposomes of Fasudil monohydrochloride microparticles and nanoparticles as dry powder inhalers using surfactant mimic-phospholipids for treatment of pulmonary arterial hypertension (PAH) | |
| HK40014165A (en) | A process for manufacturing porous silica particles loaded with at least one bioactive compound adapted for lung, nasal, sublingual and/or pharyngeal delivery | |
| Meenach et al. | Characterization and Aerosol Dispersion Performance of Spray-Dried Chemotherapeutic PEGylated Phospholipid Particles for Dry Powder Inhalation Delivery in Lung Cancer |